NVO · Novo Nordisk filed a routine 6-K update on its ongoing B share…

Novo Nordisk filed a routine 6-K update on its ongoing B share repurchase program, reporting weekly transactions from June 29 to July 3, 2026. The company has repurchased 23,009,179 B shares since February 4, 2026, for a total of DKK 6.22 billion, representing 0.9% of share capital. This is a standard periodic disclosure with no new material information.

• Novo Nordisk repurchased 1,000,000 B shares from June 29 to July 3, 2026, at an average price of DKK 320.93 per share, totaling DKK 320.93 million.
• Since February 4, 2026, the company has repurchased 23,009,179 B shares at an average price of DKK 270.32, for a total transaction value of DKK 6,219,775,971.
• The buyback is part of a program of up to DKK 15 billion over 12 months beginning February 4, 2026.
• As of July 3, 2026, Novo Nordisk holds 40,194,480 B shares as treasury shares, corresponding to 0.9% of total share capital.